Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Hetzer Medical Indonesia Tbk. (MEDS) vs Solusi Bangun Indonesia Tbk. (SMCB)

Hetzer Medical Indonesia Tbk.Trading
Solusi Bangun Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Hetzer Medical Indonesia Tbk. dan Solusi Bangun Indonesia Tbk.: Hetzer Medical Indonesia Tbk. diperdagangkan di Rp86 (kapitalisasi pasar 139,06 M, volume 24 jam 51,66 jt), sedangkan Solusi Bangun Indonesia Tbk. diperdagangkan di Rp775 (kapitalisasi pasar 6,99 T). Perbedaan utamanya: Solusi Bangun Indonesia Tbk. jauh lebih besar — sekitar 50,3× kapitalisasi pasar Hetzer Medical Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

MEDSSMCB
Kapitalisasi Pasar
139,06 M6,99 T
Volume
51,66 jt
Lot
516,62 rb
Perputaran
4,44 M
Harga Rata-rata
85,97
Nilai Transaksi
4,44 M
Harga Ekuilibrium Indikatif
86
Volume Ekuilibrium Indikatif
9,62 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

MEDS
Lihat detail
SMCB
Lihat detail

Tentang Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Selengkapnya di halaman MEDS

Tentang Solusi Bangun Indonesia Tbk.

PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.

Selengkapnya di halaman SMCB